Pamifos (Pamidronate Disodium)

Pamidronate disodium, the active ingredient in Pamifos, is a bisphosphonate presented as a sterile injectable solution for intravenous use. It is employed in the management of bone resorption disorders, particularly in patients with elevated calcium levels due to malignancy.

GNH USA supplies Pamifos as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and oncology centres worldwide.

Pamifos is a bisphosphonate that acts on disorders of bone metabolism and calcium homeostasis. - Hypercalcemia of malignancy: helps reduce the elevated serum calcium level. - Bone metastases associated with solid tumors: slows the progression of skeletal‑related events. - Osteolytic lesions in multiple multiple multiple Sclerosis ?  ??? -  ???  

}]